This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
GPI monoclonal antibody, clone 1B7D7
catalog :
MAB10351
quantity :
100 uL
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1B7D7
The same clone is also sold as:
The same clone is also sold as:
- Invitrogen: MA5-15396
- Santa Cruz Biotechnology: sc-130067
- MyBioSource: MBS246581
- OriGene: AM06224SU-N
- Abcam: ab66340
- Novus Biologicals: NBP1-47523
- Bio-Rad: VMA00315
reactivity :
human
application :
western blot, ELISA, immunocytochemistry, immunohistochemistry - paraffin section
product information
catalog id :
MAB10351
product name :
GPI monoclonal antibody, clone 1B7D7
product description :
Mouse monoclonal antibody raised against recombinant GPI.
clone name :
1B7D7
isotype :
IgG1
gene name :
GPI
gene alias :
AMF GNPI NLK PGI PHI SA-36
gene description :
glucose phosphate isomerase
immunogen :
Recombinant protein corresponding to human GPI.
form :
Liquid
recommend dilutions :
ELISA (1:10000). Western Blot (1:500-1:2000). Immunohistochemistry (1:200-1:1000). Immunofluorescence (1:200-1:1000). The optimal working dilution should be determined by the end user.
storage buffer :
In ascites (0.03% sodium azide)
storage instruction :
Store at 4 C. For long term storage store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
WB,ELISA,IHC-P,IF,WB-Tr
size :
100 uL
autodate :
2012-03-02
updatetime :
2016-12-06 11:37:34
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments